Trademark: 88583743
Word
ELIXOME
Status
Dead
Status Code
602
Status Date
Monday, October 26, 2020
Serial Number
88583743
Mark Type
4000
Filing Date
Monday, August 19, 2019
Published for Opposition
Tuesday, December 24, 2019
Abandoned Date
Wednesday, October 14, 2020

Trademark Owner History
UNICOCELL BIOMED CO., LTD. - Owner At Publication

Classifications
5 Chemical preparations for medical, pharmaceutical, biopharmaceutical and biological purposes, namely, for human transplantation or implantation, treatment, reconstruction and repair of connective tissue, epithelial tissue, muscle tissue, and nervous tissue; human allograft cells for medical purposes; human allograft tissue; human allogeneic cells for medical purposes; human allogeneic tissue; human autograft cells for medical purposes; human autograft tissue; human autologous cells for medical purposes; human autologous tissue; stem cells for medical purposes; medicinal preparations for stimulating hair growth; medicated hair care preparations; surgical implants comprising living tissue and cells; biological tissue and cell cultures for medical purposes; medical dressings; wadding for dressings

Trademark Events
Oct 26, 2020
Abandonment Notice E-Mailed - Failure To Respond
Oct 26, 2020
Abandonment - Failure To Respond Or Late Response
Apr 13, 2020
Notification Of Non-Final Action E-Mailed
Apr 13, 2020
Non-Final Action E-Mailed
Apr 13, 2020
Su - Non-Final Action - Written
Apr 10, 2020
Statement Of Use Processing Complete
Mar 24, 2020
Use Amendment Filed
Apr 10, 2020
Case Assigned To Intent To Use Paralegal
Mar 24, 2020
Teas Statement Of Use Received
Feb 18, 2020
Noa E-Mailed - Sou Required From Applicant
Dec 24, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 24, 2019
Published For Opposition
Dec 4, 2019
Notification Of Notice Of Publication E-Mailed
Nov 19, 2019
Approved For Pub - Principal Register
Nov 19, 2019
Assigned To Examiner
Sep 4, 2019
New Application Office Supplied Data Entered In Tram
Aug 22, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24